Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Leukemia, Lymphocytic, Chronic, B-Cell 140Lymphoma 116Lymphoma, Non-Hodgkin 112Leukemia, Myeloid, Acute 95Leukemia 92Myelodysplastic Syndromes 90Hodgkin Disease 68Lymphoma, B-Cell 61Leukemia, Myelogenous, Chronic, BCR-ABL Positive 53Multiple Myeloma 52Lymphoma, Mantle-Cell 52Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Recurrence 43Burkitt Lymphoma 41Hematologic Neoplasms 36Myeloproliferative Disorders 31Lymphoma, B-Cell, Marginal Zone 30Neoplasms, Plasma Cell 20Primary Myelofibrosis 19Leukemia, Biphenotypic, Acute 18Anemia, Refractory, with Excess of Blasts 18Lymphoma, T-Cell 17Leukemia, Myelomonocytic, Chronic 15Graft vs Host Disease 15Anemia, Aplastic 15Leukemia, Prolymphocytic 14Neoplasms 12Leukemia, B-Cell 12

Interventions

Cyclophosphamide 12Vincristine 10Doxorubicin 10Etoposide 8Rituximab 6Prednisone 6Cytarabine 6Dexamethasone 5Bleomycin 5Zidovudine 4Methotrexate 4Leucovorin 4Filgrastim 4Peripheral Blood Stem Cell Transplantation 3sargramostim 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vinblastine 2Polymerase Chain Reaction 2Melphalan 2Dacarbazine 2Carmustine 2Antiretroviral Therapy, Highly Active 2Allopurinol 2prednylidene 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1efavirenz 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
HIV Infections × fludarabine × Lymphoid × Clear all
NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT04083170 2025-01-01

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Fred Hutchinson Cancer Center

Phase 2 Terminated
1 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, HIV Infections, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡